Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Autoriseret Fysioterapeut Jens Amstrup Poulsen Holding ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   2.6% 4.6% 2.2% 3.6% 2.0% 2.3% 14.5% 14.5%   Credit score (0-100)   62 46 65 52 67 64 15 15   Credit rating   BBB BBB BBB BBB A BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -3.5 -3.5 -3.6 -3.8 -3.9 -4.0 0.0 0.0   EBITDA   -3.5 -3.5 -3.6 -3.8 -3.9 -4.0 0.0 0.0   EBIT   -3.5 -3.5 -3.6 -3.8 -3.9 -4.0 0.0 0.0   Pre-tax profit (PTP)   155.1 12.1 258.1 95.5 295.9 290.7 0.0 0.0   Net earnings   155.6 12.5 258.6 96.6 297.3 292.7 0.0 0.0   Pre-tax profit without non-rec. items   155 12.1 258 95.5 296 291 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   790 691 837 819 999 1,169 607 607   Interest-bearing liabilities   0.0 0.1 10.9 58.1 114 77.0 0.0 0.0   Balance sheet total (assets)   793 695 851 881 1,116 1,250 607 607   Net Debt   0.0 0.0 4.0 -8.2 55.6 20.1 -607 -607     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -3.5 -3.5 -3.6 -3.8 -3.9 -4.0 0.0 0.0   Gross profit growth   0.0% 0.0% -3.6% -3.4% -3.3% -3.2% 0.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   793 695 851 881 1,116 1,250 607 607   Balance sheet change%   6.4% -12.4% 22.5% 3.5% 26.7% 12.0% -51.4% 0.0%   Added value   -3.5 -3.5 -3.6 -3.8 -3.9 -4.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 -4.0 -5.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   20.2% 1.6% 33.4% 11.3% 30.0% 25.1% 0.0% 0.0%   ROI %   20.3% 1.6% 33.6% 11.3% 30.1% 25.2% 0.0% 0.0%   ROE %   20.3% 1.7% 33.8% 11.7% 32.7% 27.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   99.6% 99.5% 98.3% 93.0% 89.5% 93.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -1.1% -1.2% -111.7% 219.4% -1,433.9% -501.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 1.3% 7.1% 11.4% 6.6% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   200.0% 3.4% 7.0% 6.9% 4.7% 6.5% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   25.7 22.0 5.2 1.7 1.2 1.5 0.0 0.0   Current Ratio   25.7 22.0 5.2 1.7 1.2 1.5 0.0 0.0   Cash and cash equivalent   0.0 0.0 6.8 66.4 58.5 56.9 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   87.3 75.2 60.2 41.9 19.2 40.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -4 -4 -4 -4 -4 -4 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -4 -4 -4 -4 -4 -4 0 0   EBIT / employee   -4 -4 -4 -4 -4 -4 0 0   Net earnings / employee   156 13 259 97 297 293 0 0